Stephanie Verbeke

Bordeaux, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma.

Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 25, 2024

Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma.

Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 25, 2024

Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction.

Dual inhibition of BET and EP300 has antitumor activity in undifferentiated pleomorphic sarcomas and synergizes with ferroptosis induction.

Journal: Translational oncology

Published: August 06, 2024

Antitumor Effects of PRMT5 Inhibition in Sarcomas.

Antitumor Effects of PRMT5 Inhibition in Sarcomas.

Journal: Cancer research communications

Published: June 12, 2023

GSK3-beta as a candidate therapeutic target in soft tissue sarcomas.

GSK3-beta as a candidate therapeutic target in soft tissue sarcomas.

Journal: Journal of hematology & oncology

Published: September 09, 2021

MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies.

MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies.

Journal: Cancers

Published: June 22, 2020

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.

High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.

Journal: EBioMedicine

Published: April 19, 2020

ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status.

ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status.

Journal: Scientific reports

Published: August 06, 2019

CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications.

CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 07, 2018

Erratum to: Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.

Erratum to: Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.

Journal: Breast cancer research : BCR

Published: July 08, 2015

Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.

Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.

Journal: Breast cancer research : BCR

Published: July 08, 2014

PLA2R1 mediates tumor suppression by activating JAK2.

PLA2R1 mediates tumor suppression by activating JAK2.

Journal: Cancer research

Published: September 07, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026